← Back to Clinical Trials
Recruiting NCT06922071

NCT06922071 The REMINDER4Care Program for Older Adults Supported by Residential and Daycare Facilities

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06922071
Status Recruiting
Phase
Sponsor University of Coimbra
Condition Dementia Risk Factors
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-05-01
Primary Completion 2025-07-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
REMINDER4Care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2025-05-01 with a primary completion date of 2025-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Dementia incidence is rising, posing a public health challenge, but 45% of cases can be prevented by addressing modifiable risk factors. Multidomain trials show that lifestyle changes can improve cognitive function and reduce dementia risk (like the FINGER trial). The REMINDER program, a Portuguese-based dementia risk reduction protocol, was developed for community-dwelling older adults aged 55 and above. However, older adults in Residential and Daycare Facilities (RDF) have distinct needs that demand program adaptation to ensure its relevance and effectiveness. In addition, more studies are needed to evaluate the impact of multidomain interventions with older adults in RDF. To address these challenges, the REMINDER4Care program was developed as a tailored, multidomain intervention to reduce dementia risk. It emphasizes social and cognitive engagement and advances its adaptation and evaluation in Residential and Daycare Facilities (RDF). To assess efficacy, the investigators will perform a Randomized Controlled Trial.

Eligibility Criteria

Inclusion Criteria: * Aged 65 years and older * RDF users * Elementary reading and writing skills Exclusion Criteria: * Have a clinical diagnosis of dementia and/or Mini-Mental State Examination (MMSE) scores below the cutoff for the presence of dementia (MMSE \< 22-27, depending on education level) * Have a psychiatric or neurological condition that impairs cognition in the long term * Have sensory and functional deficits that compromise their participation in the neuropsychological assessment and throughout the intervention sessions

Contact & Investigator

Central Contact

Catarina L. B. Baptista, PhD Student

✉ catarinalbbaptista23@gmail.com

📞 +351 963 031 318

Principal Investigator

Catarina L. B. Baptista, PhD Student

PRINCIPAL INVESTIGATOR

University of Coimbra

Frequently Asked Questions

Who can join the NCT06922071 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Dementia Risk Factors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06922071 currently recruiting?

Yes, NCT06922071 is actively recruiting participants. Contact the research team at catarinalbbaptista23@gmail.com for enrollment information.

Where is the NCT06922071 trial being conducted?

This trial is being conducted at Coimbra, Portugal.

Who is sponsoring the NCT06922071 clinical trial?

NCT06922071 is sponsored by University of Coimbra. The principal investigator is Catarina L. B. Baptista, PhD Student at University of Coimbra. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology